SARS-CoV-2 Specific Antibody Responses and Impact for COVID-19 Disease in Ethiopia
NCT06435403
·
clinicaltrials.gov ↗
RECRUITING
Status
1000
Enrollment
OTHER
Sponsor class
Conditions
SARS CoV 2 Infection
COVID-19 Breakthrough
COVID-19 Recurrent
Sponsor
Michael Hoelscher
Collaborators
[object Object]
[object Object]